Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Thymidylate synthase as an oncogene?

J R Bertino1, D Banerjee

  • 1Cancer Institute of New Jersey, Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey, 195 Little Albany Street, New Brunswick, NJ 08903, USA. bertinoj@umdnj.edu

Cancer Cell
|April 20, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Yttrium-88 glass microsphere: A potential radiotracer for radioactive particle tracking applications.

Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine·2026
Same author

Does active case finding detect TB early in programme settings? A national-level study in India.

Public health action·2026
Same author

Axisymmetric Eigenmodes Excited by Alpha Particle Energy Gradients in JET D-T Plasmas.

Physical review letters·2026
Same author

Insights into the Chemical Durability and Structure of ZnO-Incorporated Sodium Borosilicate Glasses from Solid-State NMR.

The journal of physical chemistry. B·2025
Same author

Neutrophil-lymphocyte ratio as an early predictive biomarker for severity in patients with high altitude pulmonary edema.

Medical journal, Armed Forces India·2025
Same author

Fabry disease in the haemodialysis population: outcome of a UK screening study (SoFAH).

BMC nephrology·2025

Forced overexpression of human thymidylate synthase (TS) can induce malignancy in cells. Elevated TS levels in human cancers may drive tumor progression and correlate with its activator, E2F-1.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Thymidylate synthase (TS) is a critical enzyme in DNA synthesis.
  • Its role in cancer progression is not fully understood.
  • Previous studies have noted elevated TS levels in various human malignancies.

Discussion:

  • Rahman et al. report that overexpressing human TS transforms immortalized murine cells into a malignant phenotype.
  • This suggests a direct role for TS in cancer development.
  • The findings prompt a re-evaluation of TS as a potential driver of tumorigenesis.

Key Insights:

  • Forced TS overexpression is sufficient to induce a malignant cellular phenotype.
  • Elevated TS levels in human cancers might actively contribute to tumor progression.

Related Experiment Videos

  • Increased TS expression could be linked to the transcriptional activator E2F-1.

    • Outlook:

    • Further research is needed to elucidate the precise mechanisms by which TS overexpression drives malignancy.
    • Investigating the therapeutic potential of targeting TS or its regulatory pathways in cancer is warranted.
    • Understanding the interplay between TS and E2F-1 could reveal new strategies for cancer treatment.